Table 6 Long-term complications in non randomized trials
From: Use of vaginal mesh for pelvic organ prolapse repair: a literature review
Graft type | All kind of meshes | NAS meshes | Biologic meshes |
|---|---|---|---|
Chronic pain (buttock, groin, perinea) | 5.6% (0–24.4) | 5.8% (0–24.4) | 0.9% |
25 trials n = 3307 | 24 trials n = 3206 | 1 trial n = 101 | |
Vesicovaginal or rectovaginal fistula | 1.5% (0.3–5) | 1.6% (0.3–5) | 0.9% |
9 trials n = 1576 | 8 trials n = 1475 | 1 trial n = 101 | |
Shrinkage | 6.8% (1.3–17) | 7.9% (1.3–17) | 1.5 |
6 trials n = 1530 | 5 trials n = 1398 | 1 trial n = 132 | |
Vaginal adhesion | 3.1% (0.9–6.9%) | 3.1% (0.9–6.9%) | 0 |
5 trials n = 835 | 5 trials n = 835 | ||
Granuloma | 4.7% (0.8–13) | 4.7% (0.8–13) | 0 |
5 trials n = 533 | 5 trials n = 533 | ||
Leukorrhea | 5.6% (0–4) | 5.6% (0–4) | 0 |
4 trials n = 447 | 4 trials n = 447 |